Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Yolanda, Ruano"'
Autor:
Santiago Terán, Manuel Alva, Pablo Tolosa, Macarena Rey-Cárdenas, Ainhoa Madariaga, Laura Lema, Yolanda Ruano, Luis Manso, Eva Ciruelos, Rodrigo Sánchez-Bayona
Publikováno v:
Breast, Vol 71, Iss , Pp 42-46 (2023)
Background: HER2-low has emerged as a new predictive biomarker in metastatic breast cancer. However, its prognostic value in early-stage carcinomas needs to be revisited. We aimed to evaluate the association of HER2-low carcinomas with PAM50 risk gro
Externí odkaz:
https://doaj.org/article/45206221d7664a38bf63504773e67ed3
Autor:
Leyla Blanco-García, Yolanda Ruano, Raquel Blanco Martínez-Illescas, Rocío Cubo, Paula Jiménez Sánchez, Víctor J. Sánchez-Arévalo Lobo, Erica Riveiro Falkenbach, Pablo Ortiz Romero, María C. Garrido, José L. Rodríguez Peralto
Publikováno v:
Heliyon, Vol 9, Iss 8, Pp e18953- (2023)
Melanoma is the most aggressive form of skin cancer and the leading cause of death from cutaneous tumors. Several studies have associated alterations in the TERT promoter region (pTERT) with gene overexpression, aggressiveness and poor prognosis of t
Externí odkaz:
https://doaj.org/article/5fabe54c1f8245bfb8a824dfbf773c29
Autor:
Lucía Zhu, Diana Retana, Pedro García‐Gómez, Laura Álvaro‐Espinosa, Neibla Priego, Mariam Masmudi‐Martín, Natalia Yebra, Lauritz Miarka, Elena Hernández‐Encinas, Carmen Blanco‐Aparicio, Sonia Martínez, Cecilia Sobrino, Nuria Ajenjo, Maria‐Jesus Artiga, Eva Ortega‐Paino, Raúl Torres‐Ruiz, Sandra Rodríguez‐Perales, RENACER, Riccardo Soffietti, Luca Bertero, Paola Cassoni, Tobias Weiss, Javier Muñoz, Juan Manuel Sepúlveda, Pedro González‐León, Luis Jiménez‐Roldán, Luis Miguel Moreno, Olga Esteban, Ángel Pérez‐Núñez, Aurelio Hernández‐Laín, Oscar Toldos, Yolanda Ruano, Lucía Alcázar, Guillermo Blasco, José Fernández‐Alén, Eduardo Caleiras, Miguel Lafarga, Diego Megías, Osvaldo Graña‐Castro, Carolina Nör, Michael D Taylor, Leonie S Young, Damir Varešlija, Nicola Cosgrove, Fergus J Couch, Lorena Cussó, Manuel Desco, Silvana Mouron, Miguel Quintela‐Fandino, Michael Weller, Joaquín Pastor, Manuel Valiente, Adolfo de la Lama‐Zaragoza, Lourdes Calero‐Felix, Concepcion Fiaño‐Valverde, Pedro David Delgado‐López, Antonio Montalvo‐Afonso, Mar Pascual‐Llorente, Ángela Díaz‐Piqueras, SH Nam‐Cha, Cristina Barrena López, Gerard Plans Ahicart, Elena Martínez‐Saez, Santiago Ramón y Cajal, Pilar Nicolás
Publikováno v:
EMBO Molecular Medicine, Vol 14, Iss 3, Pp 1-29 (2022)
Abstract We report a medium‐throughput drug‐screening platform (METPlatform) based on organotypic cultures that allows to evaluate inhibitors against metastases growing in situ. By applying this approach to the unmet clinical need of brain metast
Externí odkaz:
https://doaj.org/article/192ccb44b2e3449a849f6353de0e50dd
Autor:
Belén Pérez-Mies, Tamara Caniego-Casas, Tommaso Bardi, Irene Carretero-Barrio, Amparo Benito, Mónica García-Cosío, Irene González-García, David Pizarro, Marta Rosas, Eva Cristóbal, Yolanda Ruano, María Concepción Garrido, Juan Rigual-Bobillo, Raúl de Pablo, Juan Carlos Galán, David Pestaña, José Palacios
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
The development of lung fibrosis is a major concern in patients recovered from severe COVID-19 pneumonia. This study aimed to document the evolution of diffuse alveolar damage (DAD) to the fibrosing pattern and define the transcriptional programs inv
Externí odkaz:
https://doaj.org/article/3466cc51bc6748d49dd1f88a013098ef
Autor:
Alvaro Valin, Manuel J. Del Rey, Cristina Municio, Alicia Usategui, Marina Romero, Jesús Fernández-Felipe, Juan D. Cañete, Francisco J. Blanco, Yolanda Ruano, Gabriel Criado, José L. Pablos
Publikováno v:
BMC Molecular and Cell Biology, Vol 21, Iss 1, Pp 1-12 (2020)
Abstract Introduction The clinical efficacy of specific interleukin-6 inhibitors has confirmed the central role of IL6 in rheumatoid arthritis (RA). However the local role of IL6, in particular in synovial fibroblasts (SF) as a direct cellular target
Externí odkaz:
https://doaj.org/article/d966f2637fe742f6aedba0c75a9ebd6b
Autor:
Pablo Tolosa, Tomás Pascual, Cristina Hernando, Sonia Servitja, María Fernández Abad, Fara Brasó-Maristany, Javier Benítez, Laura Lema, Mario Martínez, Yolanda Ruano, Lucía Parrilla, Alejandra Bernardini, Ana María Roncero, Laia Paré, Jordi Canes, Patricia Villagrasa, Fernando Salvador, Aleix Prat, Eva Ciruelos
Publikováno v:
Cancer Research. 82:OT2-19
Introduction. The incorporation of cyclin-dependent kinase inhibitors 4 and 6 (CDK4/6 inhibitors) with endocrine therapy in patients with hormone receptor-positive/HER2-negative (HR+/HER2-) advanced breast cancer has demonstrated its efficacy improvi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::529072b9bf19fe103fe1e299be329da5
https://doi.org/10.1158/1538-7445.sabcs21-ot2-19-03
https://doi.org/10.1158/1538-7445.sabcs21-ot2-19-03
Autor:
Susana Rojo-Alba, Marta Elena Álvarez-Argüelles, Yolanda Ruano, Zulema Pérez-Martinez, Jose Antonio Boga, María De Oña, Ana Palacio, María Concepción Solares, Santiago Melón
Publikováno v:
Applied Microbiology; Volume 2; Issue 3; Pages: 651-661
(1) Background: HPV infection can progress over the years to become cervical cancer. In this study, genotype and a normalized viral load were evaluated as surrogate markers of progression to cancer. (2) Methods: A total of 558 endocervical swabs were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17e75df13508677dbf1b1b770add37bf
Autor:
Leyla Blanco García, Yolanda Ruano Domínguez, Raquel Blanco Martínez-Illescas, Rocío Cubo Martínez, Paula Jiménez Sánchez, Víctor Sánchez-Arévalo Lobo, Erica Riveiro Falkenbach, Pablo Ortiz-Romero, María Garrido, Jose Rodriguez-Peralto
Background Melanoma is the most aggressive form of skin cancer and the leading cause of death from cutaneous tumors. Several studies have associated alterations in the TERT promoter region (pTERT) with gene overexpression, aggressiveness and poor pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::214dcdb318c22397c1881272b9446336
https://doi.org/10.21203/rs.3.rs-1881548/v1
https://doi.org/10.21203/rs.3.rs-1881548/v1
Autor:
Pablo Tolosa, Tomás Pascual, Cristina Hernando, Sonia Servitja, Adela Fernández, Fara Brasó-Maristany, Javier Benitez, Laura Lema, Yolanda Ruano, Lucia Parrilla, Ana María Roncero, Rodrigo Sánchez-Bayona, Manuel Alva, Guillermo Villacampa, María Rocío Moreno-Villa, Jordi Canes, Fernando Salvador, Aleix Prat, Eva Ciruelos
Publikováno v:
Cancer Research. 83:P5-02
Background: First-line treatment with cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) plus endocrine therapy (ET) has demonstrated efficacy in improving progression-free survival (PFS), overall response rate (ORR) and, more recently, ribociclib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d39a9d71d3bbd3eaee66862ad2b7d09
https://doi.org/10.1158/1538-7445.sabcs22-p5-02-44
https://doi.org/10.1158/1538-7445.sabcs22-p5-02-44
Autor:
Clara Gómez-González, Maria Isabel Esteban-Rodríguez, Yolanda Ruano, Elena Vallespín, Pablo Lapunzina, Paloma Martínez, Samuel I Pascual, Jesús Molano, Carmen Prior
Publikováno v:
Annals of Indian Academy of Neurology, Vol 20, Iss 2, Pp 164-165 (2017)
Externí odkaz:
https://doaj.org/article/305fe8d4fe3e41f38edb190eedddb9e9